EIKN (Eikon Therapeutics) Institutional Ownership: 48.94% (As of Sep. 04, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EIKN Eikon Therapeutics Inc EIKN
12 GF Score
Price $10.93
View Full Analysis

What is Eikon Therapeutics Institutional Ownership?

Eikon Therapeutics EIKN -3.78% 12 Institutional Ownership is 48.94% as of Sep. 04, 2026. GuruFocus rates EIKN with a GF Score™ of 12/100.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Eikon Therapeutics's institutional ownership is 48.94%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Eikon Therapeutics's Insider Ownership is 2.50%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Eikon Therapeutics's Float Percentage Of Total Shares Outstanding is 75.27%.

Eikon Therapeutics Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Eikon Therapeutics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eikon Therapeutics Institutional Ownership Chart

Eikon Therapeutics Historical Data

The historical data trend for Eikon Therapeutics can be seen below:

2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31 2026-08-31
Institutional Ownership 16.98 25.48 26.21 26.33 31.27 31.65 32.91
EIKN
12GF Score
Eikon Therapeutics Inc EIKN
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eikon Therapeutics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 48.94% mean?
Eikon Therapeutics (EIKN) has a Institutional Ownership of 48.94% as of Sep. 04, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Eikon Therapeutics and its competitors.
Is Eikon Therapeutics' Institutional Ownership too high?
Eikon Therapeutics' current Institutional Ownership is 48.94%. Overall, Eikon Therapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Eikon Therapeutics' Institutional Ownership compare to SPRY and ARVN?
Eikon Therapeutics' Institutional Ownership of 48.94% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Eikon Therapeutics and its competitors. Eikon Therapeutics's current Institutional Ownership is 48.94%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eikon Therapeutics stock overvalued right now?
Eikon Therapeutics (EIKN) has a current Institutional Ownership of 48.94%. The current Institutional Ownership is 48.94%. Eikon Therapeutics' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Eikon Therapeutics (EIKN), the current Institutional Ownership is 48.94% as of Sep. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Eikon Therapeutics Business Description

Address 230 Harriet Tubman Way, Millbrae, CA, USA, 94030
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.
12GF Score

Get the complete analysis for EIKN

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.93
Price